TuHURA Biosciences HURA
NASDAQ HURA
$1.45 -0.07 (-4.60%)
As of: Nov 12, 2026 · 9:42 AM EST

TuHURA Biosciences (HURA) Consolidated Net Income (2010 - 2026)

Updated

TuHURA Biosciences' Consolidated Net Income came in at -$7,405 for FY2012, compared with -$14,774 in FY2011.

Analysis

TuHURA Biosciences (HURA) Consolidated Net Income (2010 - 2026) Analysis & Trends

  • Per Business Quant, earlier years put Consolidated Net Income at -$14,774 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 TuHURA Biosciences 96.16 Mn 82.54 Mn - -9.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.22 Mn
Mar 31, 2026 -7.54 Mn
Dec 31, 2025 -31.77 Bn
Sep 30, 2025 -6.74 Mn
Jun 30, 2025 -9.85 Mn
Mar 31, 2025 -6.92 Mn
Sep 30, 2024 -5.60 Mn
Jun 30, 2024 -4.92 Mn
Mar 31, 2024 -4.85 Mn
Sep 30, 2015 1.62 Mn
Jun 30, 2015 299,511.00
Mar 31, 2015 1.65 Mn
Dec 31, 2014 1.08 Mn
Sep 30, 2014 1.32 Mn
Mar 31, 2014 3.20 Mn
Dec 31, 2013 865,976.00
Sep 30, 2013 -6.79 Mn
Jun 30, 2013 21.77 Mn
Mar 31, 2013 7.41 Mn
Dec 31, 2012 -3,250.00
API Access

TuHURA Biosciences Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=HURA&period=max&api_key=YOUR_API_KEY